Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

Share Price is delayed by 15 minutes
Get Live Data
5.045    0.075 (1.51%)
Bid:
4.84
Ask:
5.25
Spread: 0.41 (8.471%)
Market Cap: £8.10m
TAN Live PriceLast checked at - London Stock Exchange

Intraday Tanfield Share Chart

Interim Results

21 Aug 2019 07:00

RNS Number : 6927J
Tanfield Group PLC
21 August 2019
Β 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

Β 

Β 

Tanfield Group Plc

Β 

("Tanfield", or "the Company")

Β 

Interim Results for the six-month period to 30 June 2019

Β 

Β 

Tanfield, an investing company as defined by AIM Rules, announces its half year results for the period ending 30 June 2019. The unaudited financial information will shortly be available on the Company website atΒ www.tanfieldgroup.com.

Β 

Background

Β 

The Company is currently defined as an investing company that has two passive investments. This status resulted from the disposal of Smith Electric Vehicles in 2010 and the transfer of the Snorkel division to Snorkel International Holdings LLC ("Snorkel") in October 2013. Tanfield currently owns 49% of Snorkel and 5.76% of Smith Electric Vehicles Corp. ("Smith").

Β 

The strategy of the Company in relation to these investments is to return as much as possible of any realised value to shareholders as events occur and circumstances allow, subject to compliance with any legal requirements associated with such distributions.

Β 

Summary

Β·; As reported in the 2018 interim results, the Board impaired the Snorkel investment value to Β£19.1m, representing approximately 11.7p per share.

Β·; Smith continues to be held at a nil balance sheet value following the impairment of the investment at the end of 2015.

Β·; As reported in November 2018, the Board received a call option notice in which Xtreme, via its subsidiary SKL Holdings, requested to exercise a call option to acquire Tanfield's interest in Snorkel.Β In the request, SKL Holdings stated that the option price to acquire Tanfield's holding was $0 (nil) and that payment of the priority amount and preferred return (collectively "the Preferred Interest") was not required.

Β·; The Board did not agree with this statement and does not believe that the contractual agreements, or the circular distributed to shareholders to fully explain the terms of the transaction - and thereby seek their authority to enter in to the transaction - allow for a call option whereby Xtreme can acquire Tanfield's interest in Snorkel for a nil value. The Board therefore rejected the call option notice and discussions are ongoing.

Β·; The Board remain of the opinion that the Preferred Interest, being the calculated value placed on the assets Tanfield transferred to the joint venture, is the minimum payment required under the terms of the contractual agreements, as described in the circular, in order for Xtreme to acquire Tanfield's interest. Therefore, the Board deem this to be an appropriate basis for determining the value the investment is to be carried at.

Β·; Due to the risks involved with the ongoing different opinions regarding the contractual agreements, it is possible the actual realisation of value could be less than the current valuation. Due to these inherent uncertainties, the Board is unable to determine whether the actual outcome will be less than the current valuation of Β£19.1m, which it believes is underpinned by the value of the Preferred Interest, and so feel the valuation of Β£19.1m should be maintained.

Β·; Should Xtreme attempt to acquire Tanfield's 49% interest in Snorkel for an unacceptable value, the Board will vigorously defend its position that the Preferred Interest is payable.

Β·; The Company's operating loss in H1 2019 increased to Β£127k (H1 2018: Β£94k) as a consequence of additional legal fees during the period, with the retained loss for the period being Β£127k (H1 2018: Β£17.3m, including a Β£17.2m impairment of the Snorkel investment).

Β 

Β 

Overview of investments

Β 

Based on the unaudited financial information received from Snorkel, during the first 6 months of 2019 the business achieved further sales growth resulting in sales of US$112.5m, an increase of around 17% compared to H1 2018 when sales were US$96.3m. Should the trend of sales growth continue for the remainder of the year, the Board believes 2019 could see total sales of around US$230m (2018: US$201m).

Β 

The reported gross profit for the period was US$13.8m, an increase of $1.5m compared to H1 2018 (US$12.3m) however, the gross profit margin reduced slightly to 12.2% compared to 12.7% in H1 2018. Selling, general and administrative costs increased to US$12.7m (2018: US$11.5m) during the period, resulting in an operating profit, excluding depreciation, of US$1.1m (H1 2018 US$0.8m).

Β 

The reported EBITDA for the last 12 month period, ending June 2019, is US$3.2m. The Board did not receive the information necessary to provide a comparison for the 12 month period ending June 2018, and the closest comparison available is for the 12 month period ending September 2018, which saw a last 12 month EBITDA of US$1.8m reported.

Β 

The Board is unable to provide an opinion at this juncture on the profit expectation for the remainder of 2019.

Β 

In 2015 the investment in Smith was impaired to nil due to the uncertainty around its future and the level of funding it required. The situation continues to be monitored but the Board is of the opinion that it is highly unlikely that any value will materialise from the investment.

Β 

Β 

Β 

For further information:

Β 

Tanfield Group Plc 020 7220 1666

Daryn Robinson Β 

Β 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Lydia Zychowska 020 7220 1666

Β 

Β 

Β 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDING 30 JUNE 2019

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Six months to

30 Jun 19 (unaudited)

Six months to

30 Jun 18 (unaudited)

Year to

Β 31 Dec 18

Β (audited)

Β 

Β 

Β 

Β 

Β£000's

Β£000's

Β£000's

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Revenue

Β 

Β 

-

-

-

Β 

Staff costs

Β 

Β 

(32)

(32)

(74)

Β 

Other operating income

Β 

Β 

11

15

28

Β 

Other operating expenses

Β 

Β 

(106)

(77)

(149)

Β 

Loss from operations before impairments

Β 

Β 

(127)

(94)

(195)

Β 

Impairment of Investments

Β 

Β 

-

(17,183)

(17,183)

Β 

Loss from operations after impairments

Β 

Β 

(127)

(17,277)

(17,378)

Β 

Finance expense

Β 

Β 

-

-

-

Β 

Finance income

Β 

Β 

-

-

1

Β 

Net finance expense

Β 

Β 

-

-

1

Β 

Β 

Β 

Β 

Β 

Β 

Loss from operations before tax

Β 

Β 

(127)

(17,277)

(17,377)

Β 

Taxation

Β 

Β 

-

-

-

Β 

Loss & total comprehensive income for the period attributable to equity shareholders

(127)

(17,277)

(17,377)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss per share from operations

Β 

Β 

Β 

Β 

Β 

Β 

Basic and diluted (p)

Β 

Β 

(0.08)

(10.95)

(10.99)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β 
Β 

Β 

BALANCE SHEET

AS AT 30 JUNE 2019

Β 

Β 

Β 

Β 

Β 

30 Jun 19

(unaudited)

30 Jun 18

(unaudited)

31 Dec 18

(audited)

Β 

Β 

Β 

Β 

Β£000's

Β£000's

Β£000's

Β 

Non current assets

Β 

Β 

Β 

Β 

Β 

Β 

Non current Investments

Β 

Β 

19,100

19,100

19,100

Β 

Β 

Β 

Β 

19,100

19,100

19,100

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other receivables

Β 

Β 

35

32

11

Β 

Cash and cash equivalents

Β 

Β 

273

255

188

Β 

Β 

Β 

Β 

308

287

199

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total assets

Β 

Β 

19,408

19,387

19,299

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other payables

Β 

Β 

63

40

52

Β 

Β 

Β 

Β 

63

40

52

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total liabilities

Β 

Β 

63

40

52

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Β 

Share capital

Β 

Β 

8,145

7,920

7,920

Β 

Share premium

Β 

Β 

17,336

17,336

17,336

Β 

Share option reserve

Β 

Β 

331

331

331

Β 

Special reserve

Β 

Β 

66,837

66,837

66,837

Β 

Merger reserve

Β 

Β 

1,534

1,534

1,534

Β 

Retained earnings

Β 

Β 

(74,838)

(74,611)

(74,711)

Β 

Total equity

Β 

Β 

19,345

19,347

19,247

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total equity and total liabilities

Β 

Β 

19,408

19,387

19,299

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β Β Β Β Β Β 

Β 

STATEMENT OF CHANGES IN EQUITY

Β 

Β 

Β 

Β 

Share capital

Β 

Share premium

Β 

Share option reserve

Β 

Merger reserve

Β 

Special reserve

Β 

Retained earnings

Β 

Total

Β 

Β 

Β£000's

Β£000's

Β£000's

Β£000's

Β£000's

Β£000's

Β£000's

Six months to 30 June 2019 (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 1 January 2019

Β 

7,920

17,336

331

1,534

66,837

(74,711)

19,247

Comprehensive income

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

Β 

-

-

-

-

-

(127)

(127)

Total comprehensive income for the year

Β 

-

-

-

-

-

(127)

(127)

Transactions with owners in their capacity as owners:-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Issuance of new shares

Β 

225

-

-

-

-

-

225

Β 

At 30 June 2019

Β 

8,145

17,336

331

1,534

66,837

(74,838)

19,345

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Six months to 30 June 2018 (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 1 January 2018

Β 

7,816

17,190

331

1,534

66,837

(57,334)

36,374

Comprehensive income

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

Β 

-

-

-

-

-

(17,277)

(17,277)

Total comprehensive income for the year

Β 

-

-

-

-

-

(17,277)

(17,277)

Transactions with owners in their capacity as owners:-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Issuance of new shares

Β 

104

146

-

-

-

-

250

At 30 June 2018

Β 

7,920

17,336

331

1,534

66,837

(74,611)

19,347

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Year to December 2018 (audited)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

At 1 January 2018

Β 

7,816

17,190

331

1,534

66,837

(57,334)

36,374

Β 

Comprehensive income

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the year

Β 

-

-

-

-

-

(17,377)

(17,377)

Β 

Total comprehensive income for the year

Β 

-

-

-

-

-

(17,377)

(17,377)

Β 

Transactions with owners in their capacity as owners:-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share based payments

Β 

104

146

-

-

-

-

250

Β 

At 31 December 2018

Β 

7,920

17,336

331

1,534

66,837

(74,711)

19,247

Β 

Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β 

Β 

Β 

CASH FLOW STATEMENT

FOR THE SIX MONTHS ENDING 30 JUNE 2019

Β 

Β 

Β 

Β 

Six months to 30 Jun 19 (unaudited)

Six months to 30 Jun 18 (unaudited)

Year to

Β 31 Dec 18

Β (audited)

Β 

Β 

Β 

Β£000's

Β£000's

Β£000's

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss before interest and taxation

Β 

(127)

(17,277)

(17,378)

Β 

Loss on impairment of investments

Β 

-

17,183

17,183

Β 

Operating cash flows before movements in working capital

Β 

(127)

(94)

(195)

Β 

(Increase)/decrease in receivables

Β 

(24)

(20)

2

Β 

Increase/(decrease) in payables

Β 

11

(15)

(4)

Β 

Net cash used in operating activities

Β 

(140)

(129)

(197)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from Investing Activities

Β 

Β 

Β 

Β 

Β 

Interest received

Β 

-

-

1

Β 

Net cash from investing activities

Β 

-

-

1

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Β 

Β 

Proceeds from issuance of ordinary shares net of costs

Β 

225

250

250

Β 

Net cash from financing activities

Β 

225

250

250

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net increase in cash and cash equivalents

Β 

85

121

54

Β 

Cash and cash equivalents at the start of period

Β 

188

134

134

Β 

Cash and cash equivalents at the end of the period

Β 

273

255

188

Β 

Β Β Β Β Β Β Β Β 
Β 

Β 

1 Basis of preparation

The Interim Report of the Company for the six months ended 30 June 2019 has been prepared in accordance with AIM Rule 18 and not in accordance with IAS34 "Interim Financial Reporting" therefore is not fully in compliance with IFRS.

Β 

The half year report does not constitute financial statements as defined in Section 434 of the Companies Act 2006 and does not include all of the information and disclosures required for full annual statements. It should be read in conjunction with the annual report and financial statements for the year ended 31 December 2018 which is available on request from the Company's registered office, Sandgate House, 102 Quayside, Newcastle upon Tyne NE1 3DX or can be downloaded from the corporate website www.tanfieldgroup.com.

Β 

Β 

2 Accounting Policies

New and amended standards and interpretations effective from 1 January 2019, which have been considered by the Directors, are IFRS16 leases. Given the operational status of the company, the Directors do not think this new standard, nor any of the matters raised in the Annual Improvements projects 2014 - 2016 and 2015 - 2017, nor the amendments to IAS1 and IAS8, will have a material impact on the interim results. Therefore, the accounting policies adopted are consistent with those of the annual financial statements for the year ended 31 December 2018, as described in those financial statements. In particular, the accounts have been prepared on a going concern basis, and as set out on page 16 of those financial statements.

Β 

Β 

Β 

3 Loss per share

The calculation of the basic and diluted loss per share is based on the following data:

Β 

Β 

Number of shares

Β 

Six months

Six months

Year to

Β 

Β 

Β 

to 30 Jun 19

to 30 Jun 18

31 Dec 18

Β 

Β 

Β 

000's

000's

000's

Β 

Weighted average number of ordinary shares for the purposes of basic earnings per share

Β 

159,004

157,727

158,070

Β 

Effect of dilutive potential ordinary shares from share options

Β 

-

-

-

Β 

Weighted average number of ordinary shares for the purposes of diluted earnings per share

Β 

159,004

157,727

158,070

Β 

Β 

Β 

Loss

Β 

Six months

Six months

Year to

Β 

Β 

Β 

to 30 Jun 19

to 30 Jun 18

31 Dec 18

Β 

From operations

Β 

Β£000's

Β£000's

Β£000's

Β 

Loss for the purposes of basic earnings per share being net profit attributable to owners of the parent

Β 

(127)

(17,277)

(17,377)

Β 

Potential dilutive ordinary shares from share options

Β 

-

-

-

Β 

Loss for the purposes of diluted earnings per share

Β 

(127)

(17,277)

(17,377)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Loss per share from operations

Β 

Β 

Β 

Β 

Β 

Basic and diluted (p)

Β 

(0.08)

(10.95)

(10.99)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IR SEUFMSFUSEFA
Date   Source Headline
25th Jun 20214:35 pmRNSPrice Monitoring Extension
24th Jun 20214:40 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSFinal Results for the YE 31 Dec 20 & Notice of AGM
4th Jun 20214:41 pmRNSSecond Price Monitoring Extn
4th Jun 20214:35 pmRNSPrice Monitoring Extension
3rd Jun 20219:34 amRNSSnorkle Investment & Loan Subscription Update
20th May 20217:00 amRNSSnorkel Legal Proceedings Update
18th May 20217:00 amRNSSnorkel Investment Update
13th May 20214:41 pmRNSSecond Price Monitoring Extn
13th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20214:41 pmRNSSecond Price Monitoring Extn
4th May 20214:36 pmRNSPrice Monitoring Extension
26th Apr 20214:40 pmRNSSecond Price Monitoring Extn
26th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20211:39 pmRNSLoan Subscription & Legal Proceedings Update
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:36 pmRNSPrice Monitoring Extension
20th Nov 20209:32 amRNSSnorkel Investment Update
24th Aug 20207:00 amRNSInterim Results for the six months to 30 June 2020
30th Jul 20207:00 amRNSLoan Note Instrument
10th Jul 20207:00 amRNSSnorkel Investment Update
29th May 20202:09 pmRNSResult of AGM
19th May 202012:35 pmRNSSnorkel Investment Update
30th Apr 20204:40 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20207:01 amRNSFinal Results for 31 Dec 2019 and Notice of AGM
3rd Apr 20207:00 amRNSSnorkel Investment Update
30th Mar 20207:00 amRNSLoan Note Instrument and Snorkel Investment Update
27th Feb 20204:41 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension
31st Jan 20204:40 pmRNSSecond Price Monitoring Extn
31st Jan 20204:35 pmRNSPrice Monitoring Extension
14th Jan 20204:40 pmRNSSecond Price Monitoring Extn
14th Jan 20204:35 pmRNSPrice Monitoring Extension
31st Dec 201912:40 pmRNSSecond Price Monitoring Extn
31st Dec 201912:35 pmRNSPrice Monitoring Extension
16th Dec 20194:40 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
6th Dec 20194:40 pmRNSSecond Price Monitoring Extn
6th Dec 20194:35 pmRNSPrice Monitoring Extension
29th Nov 20194:41 pmRNSSecond Price Monitoring Extn
29th Nov 20194:35 pmRNSPrice Monitoring Extension
12th Nov 201912:00 pmRNSSnorkel Investment Update
24th Oct 20192:44 pmRNSSnorkel Investment Update
22nd Oct 20193:35 pmRNSSnorkel Investment Update
21st Oct 20194:40 pmRNSSecond Price Monitoring Extn
21st Oct 20194:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.